The $2.7 billion acquisition of HIT payer-provider services company TriZetto by IT/BPO outsourcer Cognizant indicates the value that large, largely offshored companies are seeing in health data. According to Fortune, “The combined company has more than $3 billion in healthcare revenue, as well as about $1.5 billion of potential revenue synergies over the next five years from which Cognizant can cull further gains.” Cognizant’s healthcare and life sciences sector is about 26 percent of their $8.84 billion total annual revenue, but what they haven’t had is the provider-payer software and TriZetto’s IP.
So why the big number (which exits the investors quite nicely) which nearly equals the value of the combined companies in healthcare? The trend this Editor has spotted (more…)
Verizon received a second FDA clearance for its health management software platform, and added blood glucose management monitors Telcare and Genesis Health as part of it. The first clearance, according to Mobihealthnews, covered five telehealth devices from Ideal Life. Verizon’s intentions are to ‘white label’ market the system to providers who plan to use personally gathered telehealth as part of a patient management program in integrated delivery networks (IDNs), where it is currently in trial–plus health plans and self-insured employers. Verizon’s platform also has ‘gamified’ educational and motivational functions, including its own virtual currency for rewards. If this is proven in the US, will this be marketable in the UK and EU–and will Verizon go it alone or seek partners? Hat tip again on the story to reader Mike Short via Editor Charles.